Caricamento...
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
Facing the emergence of difficult-to-treat bacterial infections, the perspective of using bacteriophages has re-gained interest in many countries. In terms of pharmaceutical classification in EU and United States, phages are considered as anti-infectious medicinal products and biological products, g...
Salvato in:
| Pubblicato in: | Front Microbiol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7287015/ https://ncbi.nlm.nih.gov/pubmed/32582101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.01161 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|